Boostrix
Payments companies reported to CMS as associated with Boostrix. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Boostrix, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Boostrix
These are the largest totals companies reported as associated with Boostrix. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Barbara Yawn | Rochester, MN | $1,138.39 | |
| Mousa Maalouf | Gulfport, MS | Internal Medicine | $264.01 |
| Amy Simpson-Waid | Gulfport, MS | Acute Care (Nurse Practitioner) | $264.00 |
| David Larosa | Gulfport, MS | Internal Medicine | $249.42 |
| Hannah Gwin | Gulfport, MS | Internal Medicine | $211.41 |
| Jennifer Sojourner | Crystal Springs, MS | Family | $181.44 |
| Jennifer Bryan | Flowood, MS | Family Medicine | $169.93 |
| Stephen Hammack | Flowood, MS | Family Medicine | $169.93 |
| Charles Ouzts | Flowood, MS | Internal Medicine | $169.91 |
| Casey Adams | Gulfport, MS | Adult Health (Nurse Practitioner) | $167.44 |
Prescribed Boostrix?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.